I have something to share with you...
| |
Reader,
You probably know me as the guy who hosts all of our live events.
But it’s also part of my role here at Stansberry Research to follow the trends our readers want to hear about or should hear about…
Topics like Bitcoin or Dr. Steve Sjuggerud's Melt Up Thesis.
To find these profitable ideas, I'm an avid reader… and I love trying new things.
For example, I taught myself how to trade options with our research, and now I'm testing out cryptocurrencies.
So when Porter Stansberry asked me to host an event about cancer, I was nervous.
I thought to myself, "People don't want to hear about cancer. I certainly don't…"
Personally, I'm a healthy eater, I exercise, and I sleep eight hours a day whenever I can. I don't want to think about getting sick… ever.
And I'm sure you don't, either.
But then Porter and biotech expert Dave Lashmet showed me a radical new cancer breakthrough. And it opened my eyes.
Frankly, I hadn't realized how much cancer treatment has changed in recent years.
(And how much money you could make in this sector right now.)
You see, Dave Lashmet has been studying cancer medicine for 20 years. He's seen just about every breakthrough along the way. (Including ID Biomedical, which is up more than 1,000% since he first wrote about it.)
But today, he believes his newest discovery could change cancer medicine forever… and make early investors huge gains.
Pretty exciting, considering that since launching his latest venture, Dave's recommended eight companies which quickly rallied at least 100%, some of which are still open recommendations and climbing.
That's why I think this is going to be one of the biggest nights in Stansberry Research history.
But it might also be the most controversial.
A lot of folks might find it strange that we're hosting a live event about cancer.
But I promise you, this event will change everything you know about modern medicine.
Even if you don't take us up on the recommendation that could make you up to 5-times your money, the information you learn could save your life or someone you love.
To learn more about this Wednesday's event and sign up, click here.
Regards,
Jared Kelly
Managing Director
Stansberry Research |
|
| |
All contents of this e-mail are copyright 2017 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at newsletter@newslettercollector.com. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to info@stansberrycustomerservice.com.
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
